课题基金 / 基金详情

Impact of a Novel Community-Based Biobehavioral Chronic Pain Team Training Program (4PCP) on Practitioner and Patient Outcomes

Impact of a Novel Community-Based Biobehavioral Chronic Pain Team Training Program (4PCP) on Practitioner and Patient Outcomes
基于社区的新型生物行为慢性疼痛团队培训计划 (4PCP) 对从业者和患者结果的影响
批准号:
10709558
负责人:
Thomas C. Chelimsky
金额:
$40.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-09-29

项目摘要

项目成果

Thomas C. Chelimsky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Impact of a Novel Community-Based Biobehavioral Chronic Pain Team Training Program (4PCP) on Practitioner and Patient Outcomes ABSTRACT Although primary care medical practitioners (PCPs) provide the first and sometimes only line of treatment for patients with chronic pain, surveys show they are generally not comfortable with its management. This may reflect a dual shortcoming in their educational preparation. First the average medical school spends 0 to 6 hours on chronic pain, when pain organizations like the International Association for the Study of Pain (IASP) suggest 74 hours. Second, medical training is primarily oriented towards a biopharmacologic framework. While drugs may help the nociceptive component of pain, and anxiety or depression, they offer little to address the core emotional, cognitive and behavioral roots of chronic pain. This biopharmacologic mindset, that a drug might “do it all”, may have set a stage for today's opioid crisis. Managing these deeper chronic pain issues requires a biopsychosocial framework, that views a chronic pain syndrome as a brain disorder, reinforced by years of negative cognitive, emotional and behavioral habits, requiring retraining through physical & behavioral activation, and cognitive restructuring. However, since this framework and skillset are foreign to most PCPs, they remain ill-prepared to manage the totality of a chronic pain syndrome. In the 4PCP (Primary Practice Physician Program for Chronic Pain) pilot, we demonstrated that PCPs eagerly learned and implemented this new framework into their practice, increasing confidence with chronic pain management, reducing visit times, and improving patient pain. That study did not formally address opioids, though physicians tapered opioids spontaneously. We now ask 2 new questions: (1) Will a dissemination-ready, fully codified, intensive version of 4PCP produce better outcomes, sustained for 2 years? (2) Will practitioners find new confidence and skills in managing pain as a team and taper opioids? In 27 practices (4 practitioners each, 108 total) in 4 cities (Bozeman, Cleveland, Madison, Milwaukee) we will teach the new curriculum, 3 practices at a time every 2 months over 18 months, using a stepped cluster design. Practices will co-train with a paired psychologist and PT to build a clinical team. For each practitioner, we will identify 10 patients with chronic pain, ideally on opioids (1080 total) for patient outcomes. We will measure 3 types of outcomes before and for 2 years after the training intervention: (1) patient improvement; (2) the change in practitioner satisfaction with care rendered and practitioner burnout; (3) the change in opioid prescribing in the enrolled patients based on state records.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of a Novel Community-Based Biobehavioral Chronic Pain Team Training Program (4PCP) on Practitioner and Patient Outcomes
  • 批准号:
    10522098
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2022
  • 负责人:
    Thomas C. Chelimsky
  • 依托单位:
ICEPAC: IC/BPS Evaluation of Psychophysiologic and Autonomic Characteristics
  • 批准号:
    8300027
  • 项目类别:
  • 资助金额:
    $68.57万
  • 财政年份:
    2009
  • 负责人:
    Thomas C. Chelimsky
  • 依托单位:
Neurophysiologic & Autonomic Characterization of Interstitial Cystitis/Painful Bl
  • 批准号:
    7878741
  • 项目类别:
  • 资助金额:
    $68.18万
  • 财政年份:
    2009
  • 负责人:
    Thomas C. Chelimsky
  • 依托单位:
ICECAN
  • 批准号:
    9337449
  • 项目类别:
  • 资助金额:
    $63.84万
  • 财政年份:
    2009
  • 负责人:
    Thomas C. Chelimsky
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: